Key Takeaway
A lab "normal range" just means your result falls within two standard deviations of the tested population, including sick, stressed, and sedentary people. "Optimal" is the tighter band where most patients report feeling best and where long-term outcomes track well. You want optimal, not just normal.
Your doctor calls and says "everything looks normal." You still feel terrible. You're tired at 3pm, your libido is gone, and your recovery from workouts takes a week. What gives? The answer is usually that "normal" on a lab report does not mean "healthy for you." It means you fell inside a statistical range built from a reference population that includes people with undiagnosed disease.
If you're running peptide therapy, whether it's BPC-157, CJC/ipamorelin, or tesamorelin, the whole point is moving biomarkers in a direction. You can't track progress with a binary "normal vs. flagged" readout. You need to read labs the way a functional medicine doc does: with context, trends, and a clear idea of what optimal actually looks like.
This guide shows you how. Before you start, make sure you've pulled the right panel. Our complete pre-peptide lab panel covers every marker worth tracking.
What does "normal range" actually mean on a lab report?
A normal range is a statistical construct, not a health target. Labs build reference ranges by testing thousands of people who come through the draw station, calculating the mean, and marking everything within two standard deviations (roughly 95% of that population) as "normal." If your number falls inside that band, you get no flag.
Here's the problem. The reference population includes people with subclinical thyroid disease, low-grade inflammation, undiagnosed insulin resistance, and early hypogonadism. Roughly 30-40% of adults in the US carry at least one metabolic or hormonal issue that hasn't been formally diagnosed. Those people are still in the reference pool.
So when your testosterone comes back at 320 ng/dL and the range reads 264-916, you're flagged as "normal." But you're also in the bottom 10% of men aged 30-50, right next to patients who meet clinical criteria for hypogonadism. Normal, in this case, is a floor you barely cleared. Optimal, by contrast, is where symptoms resolve and long-term outcomes look best.
Functional medicine ranges try to fix this by using narrower bands drawn from healthy, asymptomatic populations. They're not regulatory ranges. Your insurance won't cover treatment based on them. But they're far more useful for guiding peptide or hormone therapy.
Normal vs optimal: the reference table
| Marker | Standard "normal" range | Optimal range | Units |
|---|---|---|---|
| Testosterone, total (men) | 264-916 | 600-900 | ng/dL |
| IGF-1 | Age-adjusted band | 75th-90th percentile for age | ng/mL |
| Vitamin D (25-OH) | 30-100 | 50-80 | ng/mL |
| TSH | 0.45-4.5 | 1.0-2.0 | mIU/L |
| hsCRP | <3.0 | <1.0 | mg/L |
| Fasting insulin | <25 | <5 | uIU/mL |
| HbA1c | <5.7 | 5.0-5.4 | % |
| Ferritin | 30-400 | 70-150 | ng/mL |
Common peptide lab patterns and what they mean
Individual numbers tell you a little. Patterns tell you a lot. Here are the four patterns that show up most often in peptide patient panels, and what each one points to. Learning to spot these is the difference between flailing and actually adjusting your protocol with intent.
Low testosterone plus low LH points to secondary hypogonadism. Your pituitary isn't sending the signal to your testes. This is the pattern you see in men who've done cycles of exogenous testosterone, carry high body fat, or have elevated prolactin. GHRH or GHRP peptides don't fix this. You'd look at hCG, enclomiphene, or kisspeptin analogs.
Low testosterone plus high LH is primary hypogonadism. The signal is loud, the testes aren't responding. This is usually testicular damage, aging, or genetic. Peptides targeting the HPG axis won't help much. You're looking at TRT.
High TSH plus low free T4 is classic primary hypothyroidism. Your thyroid itself is failing. No amount of peptide work fixes this; you need thyroid hormone replacement. But this pattern explains why growth hormone peptides like CJC-1295 and ipamorelin underperform in some patients. If T4 is low, IGF-1 response is blunted.
Normal TSH plus low free T3 is a conversion issue. Your body isn't flipping T4 into active T3, often because of low selenium, high reverse T3 from chronic stress, or ferritin under 50. This is a functional finding. Standard medicine will call you "normal" and move on. You won't feel normal.
When to worry about a flagged result vs when to wait
Not every abnormal number requires panic. The rule of thumb: a single out-of-range result with no symptoms means repeat the test in 2-4 weeks before acting. Labs have biological variability plus analytical variability. A 10-15% swing between draws on the same patient is common for hormones.
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for physician-supervised GLP-1 therapy.
Try the BMI Calculator →What changes that calculus is trends and symptoms. Three consecutive results showing the same pattern, even if each one is "borderline normal," is real. That's signal, not noise. Act on it. One borderline-low free T3 plus cold intolerance, hair loss, and 2pm fatigue is also real even if the absolute number is inside the reference range.
Symptomatic patients with abnormal labs get treated faster. Asymptomatic patients with one odd number get a repeat draw. Morning cortisol at 22 when the top of range is 21 and you feel fine? Repeat in a month. Morning cortisol at 22 when you're waking at 3am with anxiety? Work it up now.
The other thing to watch: direction of travel. IGF-1 drifting from 180 to 160 to 140 over three quarters, even all "normal," is a trend. Something is changing. That's where you call your provider.
Why the same test at different labs gives different numbers
This trips up almost every patient who switches labs mid-protocol. The same blood drawn on the same morning, split between LabCorp and Quest, can come back 15-20% apart on testosterone, IGF-1, and thyroid markers. Neither lab is wrong. They're using different assay platforms, different antibody reagents, and different calibration curves.
IGF-1 is the worst offender. LabCorp's IGF-1 reference ranges are built on a different assay than Quest's, and the two don't map cleanly onto each other. If you're tracking growth hormone peptide response, stick with one lab across the whole protocol. Switching labs mid-cycle is like weighing yourself on a different scale every week: you can't trust the trend.
Testosterone has a similar problem. LC-MS/MS testing (liquid chromatography-mass spectrometry) is the gold standard and what most research uses. Immunoassay testosterone, which is cheaper, runs about 10-15% higher in most men. If your doctor's in-office quick test says 650 and your LabCorp LC-MS/MS says 520, both can be right. The LC-MS/MS number is the one you'd use for clinical decisions.
Our guide on ordering peptide labs without a doctor covers which lab platforms to pick and why it matters for tracking.
How peptides shift your numbers
Different peptides move different markers. Knowing which markers to track for which protocol saves you money and prevents you from chasing the wrong signal.
Growth hormone peptides (CJC-1295, ipamorelin, sermorelin, tesamorelin). The main marker is IGF-1. Expect a 30-60% rise from baseline within 6-8 weeks on a properly dosed protocol. IGF-BP3 often moves in parallel. Fasting glucose and HbA1c can drift up slightly; this is expected and reversible. Don't track GH levels directly. They're pulsatile and essentially meaningless on a single draw.
BPC-157 and TB-500. No reliable biomarker to track. You're measuring symptoms, function, and inflammation. hsCRP can drop if you started elevated. Most of the signal is subjective: pain, range of motion, recovery time.
Tesamorelin specifically. Visceral adipose tissue on DEXA or CT scan is the registered endpoint. IGF-1 rises. Triglycerides often drop 10-20%. HbA1c may bump up 0.1-0.2%.
Kisspeptin and gonadorelin analogs. Track LH, FSH, and downstream testosterone or estradiol. Expect response within weeks, not months.
For a deeper dive into hormone marker interpretation, see our peptide hormone panel guide covering testosterone, estradiol, and the full HPG axis.
When to escalate to a physician
Some patterns are not DIY territory. Call a doctor, ideally a board-certified endocrinologist or functional medicine physician, if any of these show up on your labs.
IGF-1 above the 97th percentile for your age while on GH peptides means you're overdosed. Acromegaly risk, insulin resistance, and cardiac strain go up. Drop the dose and repeat in 6 weeks. If it stays high off protocol, get imaged.
Fasting insulin above 15 uIU/mL, HbA1c above 5.7%, or a new rise of 0.3% or more in HbA1c while on peptides needs a physician call. GH peptides can worsen insulin resistance in susceptible patients. This is real and documented.
TSH above 10 mIU/L, or free T4 below the reference range, is clinical hypothyroidism. Not something to manage with peptides or supplements.
Prolactin above 25 ng/mL (men) or above 30 (non-pregnant women) warrants a pituitary workup. Prolactinomas are benign but need imaging.
Hematocrit above 52%, especially on testosterone or peptide protocols that affect erythropoiesis, means stop and talk to a doctor. Hyperviscosity and clot risk go up sharply above 54%.
If you want a physician who actually reads labs for optimization rather than just "normal vs flagged," our provider directory lists peptide-literate clinicians. You can also start a consultation with a FormBlends-affiliated prescriber.
Frequently asked questions
What's the difference between "normal" and "optimal" lab ranges?
Normal is the statistical range covering 95% of the tested population, including sick and subclinical patients. Optimal is a tighter band drawn from healthy, asymptomatic people where symptoms resolve and long-term outcomes track well. Most optimization protocols target the optimal band, not the normal band.
How often should I retest my peptide labs?
Baseline before starting, then 6-8 weeks after starting or adjusting a protocol, then every 3 months if you're stable. If you change dose or add a new peptide, restart the clock with a 6-8 week follow-up. Single peptide patients often drop to every 6 months once dialed in.
Why did my testosterone result change 100 points between two labs?
Different assay platforms, different reference antibodies, and normal day-to-day biological variability. Testosterone can swing 15-20% within a week in the same person. Always use the same lab and the same testing method (LC-MS/MS preferred) when tracking trends.
My IGF-1 is in the "normal" range but I feel worse on GH peptides. What's going on?
Normal IGF-1 covers a huge spread. Going from the 70th percentile to the 40th percentile keeps you "normal" but your body notices. Check age-adjusted percentile, not just the number. Also check fasting insulin and free T3, since GH peptides stress both.
Do I need to fast before peptide labs?
For hormone panels including testosterone, estradiol, LH, FSH, and IGF-1, fasted status matters less than timing. Draw between 7-9am. For insulin, glucose, HbA1c, and full lipids, a 10-12 hour fast is required. hsCRP can be drawn non-fasted.
Can I interpret my labs without a doctor?
You can understand what the numbers mean and spot patterns. You should not self-prescribe based on them, especially for hormone replacement or peptides affecting the HPG axis. Use lab interpretation to ask better questions of a physician who knows peptides.
What if my symptoms improve but my labs don't change?
Trust symptoms first, labs second. Patient-reported outcomes (energy, sleep, libido, recovery, body composition) are the real endpoint. Labs are surrogates. If you feel good and your safety markers (hematocrit, HbA1c, liver enzymes) look fine, you're winning, regardless of whether your IGF-1 ticked up 20 points.
Last reviewed: 2026-04-17.
Medical disclaimer: This article is for educational purposes only and is not medical advice. Always consult your healthcare provider before starting any medication. Individual results vary. FormBlends is a licensed telehealth platform; nothing here replaces a personal clinical evaluation.